威高血净:股票交易异常波动公告

Core Points - The company, Weigao Blood Products, announced that its stock price experienced an abnormal fluctuation, with a cumulative increase of over 20% in closing prices over two consecutive trading days on November 3 and 4, 2025 [1] - The company conducted a self-examination and confirmed that its current operating conditions are normal, with no significant fluctuations in costs or sales [1] - There have been no major changes in the operating environment, market conditions, or industry policies affecting the company [1]